Baxter International (BAX) Income from Continuing Operations (2009 - 2026)
Baxter International (BAX) reported Income from Continuing Operations of 17000000.0 for Q1 2026, down 126.56% year-over-year from 64000000.0 in Q1 2025, and down 126.56% quarter-over-quarter from 64000000.0 in Q1 2025.
Baxter International (BAX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Income from Continuing Operations data on file, last reported at 17000000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 17000000.0, down 126.56% year-over-year; the trailing twelve-month figure through Mar 2026 was 2039000000.0 (down 33.95% YoY), and the FY2025 annual result was 900000000.0, down 176.07% from the prior year.
- Income from Continuing Operations eased to 17000000.0 in Q1 2026 per BAX's latest filing, from 64000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1033000000.0 in Q3 2024 and troughed at 2991000000.0 in Q3 2022.
- A 5-year average of 18615384.62 and a median of 64000000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations tumbled 1475.0% in 2022, then soared 1925.49% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 315000000.0 in 2022, then jumped by 202.54% to 323000000.0 in 2023, then jumped by 196.9% to 959000000.0 in 2024, then tumbled by 93.33% to 64000000.0 in 2025, then sank by 126.56% to 17000000.0 in 2026.
- Business Quant data shows BAX's Income from Continuing Operations at 17000000.0 in Q1 2026, 64000000.0 in Q1 2025, and 959000000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.00 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 959.00 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 39.00 Mn |
| Dec 31, 2023 | 323.00 Mn |
| Sep 30, 2023 | 51.00 Mn |
| Jun 30, 2023 | -193.00 Mn |
| Dec 31, 2022 | -315.00 Mn |
| Sep 30, 2022 | -2.99 Bn |
| Jun 30, 2022 | 185.00 Mn |
| Mar 31, 2022 | 73.00 Mn |
| Dec 31, 2021 | -20.00 Mn |
| Sep 30, 2021 | 452.00 Mn |
| Jun 30, 2021 | 301.00 Mn |
| Mar 31, 2021 | 300.00 Mn |
| Dec 31, 2020 | 171.00 Mn |
| Sep 30, 2020 | 359.00 Mn |
| Jun 30, 2020 | 247.00 Mn |